USPSTF releases draft guidelines on PSA testing

USPSTF releases draft guidelines on PSA testing

The Washington Post (4/11, McGinley) reports the US Preventive Services Task Force (USPSTF) “has dropped its controversial opposition to routine screening for prostate cancer, and now says that men between the ages of 55 and 69 should discuss the test’s potential benefits and harms with their” physicians “and make decisions based on their own ‘values and preferences.’” The group said in proposed new guidelines on Tuesday morning, “The decision about whether to be screened for prostate cancer should be an individual one.”

        The New York Times (4/11, Rabin, Subscription Publication) “Well” blog reports that the task force “continues to recommend that men 70 and older forgo screening altogether.”

        USA Today (4/11, Miller) reports that the USPSTF’s “2012 advice against screening said there was little evidence that PSA screening was reducing deaths.” Since that time, “PSA screening rates have declined by as much as 10%, and now fewer than one-third of US men get the tests.” Meanwhile, “fewer men are being diagnosed with early-stage disease, when it is more treatable, while more are being diagnosed with more aggressive harder-to-treat cancer.”

        The AP (4/11, Tanner) reports, “The draft prostate cancer recommendations, announced online in the Journal of the American Medical Association, are open for public comment...until May 8.”